Literature DB >> 15726351

Is whole-body FDG-PET valuable for health screening? Against.

Matthias Weckesser1, Otmar Schober.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15726351     DOI： 10.1007/s00259-005-1775-2

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  11 in total

Review 1.  Screening for lung cancer.

Authors:  E F Patz; P C Goodman; G Bepler
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

Review 2.  An overview of the status of imaging screening technology for breast cancer.

Authors:  J A Smith; E Andreopoulou
Journal:  Ann Oncol       Date:  2004       Impact factor: 32.976

3.  Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study.

Authors:  Gerd Assmann; Paul Cullen; Helmut Schulte
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

4.  Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings.

Authors:  J P Drenth; F M Nagengast; W J Oyen
Journal:  Eur J Nucl Med       Date:  2001-10-19

5.  Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan.

Authors:  Yen-Kung Chen; Chia-Hung Kao; Alfred C Liao; Yeh-You Shen; Chen-Tau Su
Journal:  Anticancer Res       Date:  2003 Sep-Oct       Impact factor: 2.480

6.  The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening.

Authors:  Y Y Shen; C T Su; G J S Chen; Y K Chen; A C F Liao; F S Tsai
Journal:  Neoplasma       Date:  2003       Impact factor: 2.575

7.  Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.

Authors:  Ugo Pastorino; Massimo Bellomi; Claudio Landoni; Elvio De Fiori; Patrizia Arnaldi; Maria Picchio; Giuseppe Pelosi; Peter Boyle; Ferruccio Fazio
Journal:  Lancet       Date:  2003-08-23       Impact factor: 79.321

8.  Estimation of absorbed dose for 2-[F-18]fluoro-2-deoxy-D-glucose using whole-body positron emission tomography and magnetic resonance imaging.

Authors:  H M Deloar; T Fujiwara; M Shidahara; T Nakamura; H Watabe; Y Narita; M Itoh; M Miyake; S Watanuki
Journal:  Eur J Nucl Med       Date:  1998-06

9.  Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison.

Authors:  Harry Agress; Benjamin Z Cooper
Journal:  Radiology       Date:  2003-12-29       Impact factor: 11.105

10.  Application of positron emission tomography imaging to cancer screening.

Authors:  S Yasuda; M Ide; H Fujii; T Nakahara; Y Mochizuki; W Takahashi; A Shohtsu
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640
View more
  7 in total

1.  The efficiency of healthcare facilities providing PET cancer screening in Japan.

Authors:  Xuanxiu Liu
Journal:  Jpn J Radiol       Date:  2011-12-23       Impact factor: 2.374

2.  Positron-Emission Tomography-Computed Tomography for Cancer Screening: Boon or Bane.

Authors:  Pankaj Kumar Garg; Aakanksha Goel; Bhupendra Kumar Jain
Journal:  Indian J Surg       Date:  2016-07-21       Impact factor: 0.656

3.  The value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in asymptomatic examinees with unexplained elevated blood carcinoembryonic antigen levels.

Authors:  Wenfeng Li; Weiwei Yin; Rongying Ou; Ting Chen; Lingling Xiong; Dezhi Cheng; Deyao Xie; Xiangwu Zheng; Yunsheng Xu; Liang Zhao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-24       Impact factor: 9.236

4.  Comparison of FDG-PET/CT for Cancer Detection in Populations With Different Risks of Underlying Malignancy.

Authors:  Hung-Pin Chan; Wen-Shan Liu; Wen-Shiung Liou; Chin Hu; Yu-Li Chiu; Nan-Jing Peng
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

5.  Quantitative Analysis of Torso FDG-PET Scans by Using Anatomical Standardization of Normal Cases from Thorough Physical Examinations.

Authors:  Takeshi Hara; Tatsunori Kobayashi; Satoshi Ito; Xiangrong Zhou; Tetsuro Katafuchi; Hiroshi Fujita
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

6.  The current status of an FDG-PET cancer screening program in Japan, based on a 4-year (2006-2009) nationwide survey.

Authors:  Ryogo Minamimoto; Michio Senda; Seishi Jinnouchi; Takashi Terauchi; Tsuyoshi Yoshida; Takeshi Murano; Hiroshi Fukuda; Takeshi Iinuma; Kimiichi Uno; Sadahiko Nishizawa; Eriko Tsukamoto; Hiroshi Iwata; Takeshi Inoue; Kazuhiro Oguchi; Rumi Nakashima; Tomio Inoue
Journal:  Ann Nucl Med       Date:  2012-10-20       Impact factor: 2.668

7.  Pancreatic solid incidentalomas.

Authors:  Erwin Santo; Iddo Bar-Yishay
Journal:  Endosc Ultrasound       Date:  2017-12       Impact factor: 5.628
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.